Eleven consecutive patients who met these criteria were matched to control patients by sex, type of heart disease, ejection fraction (when available), treatment with other cardiovascular drugs, age, and, when possible, treatment with type la antiarrhythmic agents. Control patients were selected at random from a database of patients who had undergone exercise testing. The database provided information about age, sex, and heart disease. None of the control patients who were treated with type Ia antiarrhythmic agents had clinical evidence of worsening arrhythmia during drug therapy. Standard exercise treadmill testing in the absence of all antiarrhythmic drugs was performed in all case and control patients. Because of the variable workload achieved by the patients at maximal exercise, the effects of exercise on the QT interval were determined after 3 minutes of exercise, an endpoint reached by every patient. The QT interval was defined as the time between the first deflection from the isoelectric PR baseline to the end of the T wave at the isoelectric TP segment. If a P wave was inscribed on a downstroke of the T wave, the end of the QT segment was defined at this point. It should be noted that this latter definition tended to underestimate the overall QT interval with exercise and was a factor in two case patients but in only one control patient; therefore, any differences noted between the groups were actually underestimated. The QT and RR intervals were measured at rest and after 3 minutes of exercise. QT intervals were corrected for rate (QTc) by the Bazett method.13 QT intervals were read independently by three observers, one of whom was unaware of grouping to ensure lack of bias. Intervals reported in the manuscript were arrived at by consensus, but the statistical conclusions were similar for each of the readings.
Electrophysiologic testing was performed in the fasting, drug-free, and nonsedated state. Up to three extrastimuli were introduced from two right ventricular sites at two drive cycle lengths, as previously described.14 In two patients, only two extrastimuli were used. Nonsustained arrhythmias were those lasting from 5 beats to 30 seconds. Sustained arrhythmias were those lasting more than 30 seconds. Polymorphic ventricular tachycardia had beat-to-beat changes in tachycardia morphology and cycle length.
Statistical analysis was performed by repeatedmeasures analysis of variance with one grouping factor (case vs. control) and one repeated measure (rest vs. exercise). Unpaired tests that were corrected for multiple comparisons were used to analyze differences in means when appropriate. Event frequencies were compared by x2 tests. Multiple regression analysis was used to examine the correlation between hemodynamic (blood pressure and heart rate) and electrocardiographic variables. All data are presented as mean±SEM. A two-tailed value ofp<0.05 was considered significant.
Results

Clinical Characteristics
Shown in Table 1 are clinical characteristics of the 11 case patients and their matched control patients. Clinical makeup was similar in both groups. Mean age was 56±5 years for the case patients and 58±5 years for the control patients. Mean ejection fraction was 48+6% for the case patients and 45+4% for the control patients.
Antiarrhythmic therapy was initiated in six case patients because of nonsustained ventricular tachycardia, in two to convert supraventricular tachycardias to sinus rhythm, and in three because of symptomatic ventricular ectopy. Indications for treatment in individual patients is shown in Table 1 . Electrophysiologic testing in the absence of antiarrhythmic drugs was negative for inducible sustained ventricular arrhythmias in all but one of the 11 case patients ( Table 2) . That patient did not have an electrophysiologic study.
Proarrhythmia
All cases developed documented polymorphic ventricular tachycardia. Characteristics of the arrhythmia are shown in Table 2 . Two had cardiac arrest, six had syncope, one had presyncope, and two had palpitations. Corrected QT intervals were available for eight of the 11 case patients at the time of proarrhythmia. The corrected QT interval was prolonged in all patients (mean, 565 +55 msec). Serum potassium was available at the time of arrhythmia in nine of 11 patients. The mean serum potassium was 4.2+0.7 mmol/l and was low (<3.5 mmol/l) in only one.
Exercise Testing
Exercise was associated with a decrease in the QT interval in both groups. There was, however, a significant difference in the degree of the QT interval change with exercise in the case patients as compared with the control patients. A blunted QT interval shortening in response to exercise was seen in each patient with a history of a proarrhythmic response to type Ia antiarrhythmic agents. Shown in Figure 1 are summary data for the 11 Drug-induced polymorphic ventricular tachycardia, which occurs frequently in the first 48 hours of drug therapy,19 has several clinical features consistent with those of congenital long QT syndrome; these features include prolonged QT intervals, a long-short initiation sequence,20 and exacerbation by bradycardia and hypokalemia. Type Ia-induced polymorphic ventricular tachycardia has been thought of as an idiosyncratic response unrelated to drug blood levels, heart disease, or other factors. 8 It has long been recognized that occasional patients with a congenital long QT syndrome may have normal QT intervals at times. Garza et a121 reported a patient who had a prolonged QT interval that was evident only during exercise but, nonetheless, had clinical manifestations of the long QT syndrome. In addition, in the registry of the long QT syndrome, several family members at risk for arrhythmic manifestations were found, at times, to have normal intervals on the resting electrocardiogram.22 Thus, in patients with the congenital long QT syndrome, a basic abnormality of myocardial repolarization may be evident in some patients at rest, whereas in others it is latent and clinically expressed under certain conditions (bradycardia, electrolyte abnormality, stress, and catecholamine excess).
Although type la antiarrhythmic agents prolong the QT interval in most patients, new polymorphic ventricular tachycardia is uncommon. It is possible that patients who exhibit a proarrhythmic response to type Ia antiarrhythmics also exhibit a latent long QT syndrome rather than having an idiosyncratic response to these drugs. The QT interval in our patients was normal at rest but was prolonged paradoxically during exercise; these findings suggest that repolarization is abnormal. This possible "latent long QT syndrome" may lead to an increased sensitivity to type la agents. Although this suggestion remains a hypothesis, the chronotropic response to exercise, the response of the QRS duration to exercise, and the change in blood pressure with exercise were similar in the two groups and, thus, were not responsible for the observed changes in the QT interval.
Not only does this study suggest that patients who develop worsening of arrhythmia while taking type la antiarrhythmic agents may have a newly described form of latent long QT syndrome, but the findings of this study also have direct clinical relevance. Torsade de pointes is common and may occur in 0.5-4% of patients with quinidine and be fatal in as high as 12% of those.91023 Prior attempts at prediction of the occurrence of this syndrome have been largely unsuccessful. We have demonstrated that there was a prolongation of the corrected QT interval with exercise in case patients with a proarrhythmic response to type Ia antiarrhythmic agents but that it remains essentially unchanged or shortens in control patients. These results suggest that exercise testing may be a useful screening test to predict which patients are most likely to develop worsening of arrhythmia during the administration of type Ia antiarrhythmic agents. This method is especially attractive because it is simple and noninvasive. Whether exercise testing will prove to have adequate sensitivity and specificity for the prediction of polymorphic ventricular tachycardia will require study in a larger number of patients.
Limitations
There are several limitations to this study. First, the onset and cessation of the QT interval may be difficult to define. This is especially true of the end of the T wave, which is asymptotic and represents terminal repolarization forces of the myocardium. In addition, with increased heart rates, the P wave may encroach on the T wave. A subset of recordings was read by an unbiased observer. In addition, the end of the QT interval in those case patients in whom the P wave encroached on the T wave was defined as the initial portion of the P wave deflection. Finally, only a small number of patients are included in this study. To determine the sensitivity and specificity of the QT change with exercise for the prediction of a proarrhythmic effect with type Ia antiarrhythmic drugs, a prospective study in a larger group of patients will be required.
